Evimero
Evimero is an interdisciplinary company focused on understanding the interactions between microorganisms and human health, agriculture, and the environment. Utilizing Systems Biology and AI/ML, Evimero aims to apply microbiome science to improve health outcomes and environmental sustainability through targeted interventions in dysbiotic microbiomes.
What We Do
A patented technology platform that rapidly discovers key molecules involved in dysbiotic microbiomes and neutralizes their negative effects. It utilizes a Causal Generative Artificial Intelligence (CGAI) framework to create high-resolution maps of microbiome pathways, applicable in healthcare, agriculture, and environmental settings.
A complete solution for rapid response to infectious diseases, from laboratory identification to diagnostic and therapeutic development, significantly reducing development time and costs compared to traditional drug discovery.
Application Area
News & Updates
This article discusses insights from the study of human microbiomes and emerging applied therapeutics.
Research on avian antibodies as a response to the COVID-19 pandemic, focusing on their ability to inhibit SARS-CoV-2.
Feasibility of avian antibodies as prophylaxis against enterotoxigenic escherichia coli colonization
This study evaluates the use of avian immunoglobulins as a preventive measure against ETEC-related diarrheal illness.
Research on the potential of avian antibodies to prevent infections caused by human norovirus, a leading cause of viral diarrhea.